Does Naltrexone Affect Your Blood Pressure?

Naltrexone, on its own, does not appear to cause meaningful blood pressure changes in most people who take it. The picture is more complicated than that simple answer, though, because the drug interacts with the body’s opioid system, which does play a role in blood pressure regulation. Whether naltrexone nudges your blood pressure in one direction or another depends heavily on your starting point: whether you already have hypertension, whether you’ve been using opioids, and whether you’re taking naltrexone alone or in a combination product like Contrave.

How Your Body’s Own Opioids Influence Blood Pressure

Your body produces its own opioid-like chemicals, often called endogenous opioids, and these molecules do more than just modulate pain. They also participate in regulating cardiovascular function, including blood pressure and heart rate. Research in animal models has shown that the level of activity in this endogenous opioid system directly correlates with blood pressure. In a study using two lines of mice bred for high and low opioid system activity, the mice with a less active opioid system had higher resting blood pressure, while mice with a more active opioid system had lower resting blood pressure.¹ The researchers traced the higher blood pressure to impaired relaxation of blood vessel smooth muscle, suggesting the opioid system helps keep vessels flexible and open.

Naltrexone works by blocking opioid receptors. That means it can interfere with whatever blood-pressure-regulating work the endogenous opioid system is doing. But how that interference plays out depends on the baseline state of the system. In animals with an already-hyperactive opioid system, blocking those receptors with an opioid antagonist raised blood pressure. In animals with low opioid activity, blocking the receptors didn’t change much, because there wasn’t much opioid signaling to block in the first place.¹ This is one reason the clinical picture is so inconsistent: the same drug can theoretically push blood pressure up, push it down, or do nothing at all depending on what the opioid system is doing when you take it.

Naltrexone and Hypertension

Some of the most striking blood pressure effects from opioid receptor blockade show up in people and animals that already have elevated blood pressure. In spontaneously hypertensive rats, a single small dose of naltrexone injected into the brain produced a significant drop in mean arterial blood pressure of about 19 mmHg compared to baseline. The same dose had no effect at all in rats with normal blood pressure.² The finding supports the idea that in a hypertensive state, endogenous opioids may actually be contributing to the elevated pressure, so blocking them brings it down.

Human data paints a similar, though somewhat murkier, picture. In hypertensive patients experiencing an acute spike in blood pressure, the short-acting opioid antagonist naloxone (a close pharmacological relative of naltrexone) significantly reduced blood pressure, heart rate, opioid levels, and catecholamines within ten minutes of administration. In normotensive control subjects, the same drug did nothing measurable.³ Researchers interpreted this as evidence that during stress-triggered blood pressure spikes, the opioid system actively contributes to the spike, and blocking it interrupts that process.

A reasonable takeaway from this body of work is that if your blood pressure is normal and stable, naltrexone is unlikely to budge it. If you already have hypertension, particularly during acute elevations, opioid receptor blockade might actually lower pressure somewhat, at least transiently. But most of the hypertension-specific evidence comes from animal models and acute-intervention studies. Nobody has run a large trial giving naltrexone long-term to hypertensive patients specifically to see if it lowers their blood pressure, so treating it as an antihypertensive is premature.

What Happens in Healthy People at Rest

If you’re a person without hypertension and without a history of opioid use, the evidence suggests naltrexone simply doesn’t change your blood pressure in any clinically relevant way. A double-blind crossover study gave 19 healthy participants either 50 mg of naltrexone or a placebo, then measured blood pressure, heart rate, catecholamines, and cortisol during a cold pressor task (a standard stress test that involves putting your hand in ice water). The researchers found no significant differences between the naltrexone and placebo sessions on any of those cardiovascular measures.⁴

This is reassuring for the large number of people who take naltrexone for alcohol use disorder or at low doses for off-label purposes. In someone whose opioid receptors are operating normally and whose blood pressure is in a healthy range, blocking those receptors doesn’t appear to tip the cardiovascular balance in either direction. The body seems to have enough redundancy in its blood pressure regulation that losing the opioid component doesn’t create a noticeable gap.

Extended-Release Naltrexone in People Recovering From Opioid Use

The situation gets more nuanced for people taking naltrexone as part of treatment for opioid use disorder, because these individuals come into treatment with a cardiovascular system that’s been reshaped by chronic opioid exposure. A study comparing extended-release naltrexone (the monthly injection, sometimes called XR-NTX) in people who had been using heroin versus people who had been using prescription opioids found notably different blood pressure responses between the two groups.

In the heroin users, treatment with extended-release naltrexone led to a significant decrease in diastolic blood pressure, with systolic blood pressure also declining at a trend level. In the prescription opioid users, no such decrease occurred; if anything, their systolic pressure crept slightly upward.⁵ The authors noted this divergence has implications for cardiovascular health in people recovering from different types of opioid dependence.

Why the difference? The heroin group may have had more profound alterations in their opioid system from the pharmacological profile of heroin use, including potentially more endogenous opioid dysregulation that naltrexone corrected. Prescription opioid users might have a different baseline cardiovascular profile. Whatever the mechanism, the finding highlights that naltrexone’s blood pressure effects in recovery depend partly on what substance the person was using and for how long. Clinicians managing cardiovascular risk in these patients should be aware that not everyone responds the same way.

The Bupropion-Naltrexone Combination Is a Different Story

If you’ve come across warnings about naltrexone and blood pressure, there’s a good chance the concern was actually about naltrexone-bupropion (brand name Contrave), a combination used for weight management. Bupropion is an antidepressant that inhibits the reuptake of norepinephrine and dopamine, and norepinephrine is a key player in blood pressure regulation. When the two drugs are combined, the blood pressure picture changes considerably.

A systematic review and meta-regression analysis of randomized controlled trials found that changes in systolic blood pressure were greater when bupropion was given together with naltrexone compared to bupropion alone.⁶ In other words, adding naltrexone to bupropion appeared to amplify the blood pressure effects beyond what bupropion would produce on its own. This is not a trivial point, since the combination is often prescribed to people who are overweight or obese and may already carry elevated cardiovascular risk.

The blood pressure concern with Contrave is significant enough that it shows up in prescribing guidelines. Clinicians are advised to monitor blood pressure in patients starting the combination, and the drug carries warnings about its cardiovascular profile. If you’re taking naltrexone-bupropion and notice headaches, a pounding sensation in your chest, or readings creeping upward on a home blood pressure monitor, that’s worth discussing with your prescriber sooner rather than later.

An important distinction: this blood pressure concern is driven largely by bupropion’s norepinephrine effects, not by naltrexone acting alone. But the two drugs together seem to produce a bigger effect than bupropion by itself, suggesting some kind of interaction between the opioid and norepinephrine systems. So if someone tells you “naltrexone raises blood pressure,” they’re likely thinking of the combination product. Naltrexone monotherapy and naltrexone-bupropion are pharmacologically different situations.

Precipitated Withdrawal and Acute Blood Pressure Surges

One scenario where naltrexone can cause dramatic and dangerous blood pressure changes is precipitated withdrawal. If someone takes naltrexone while they still have opioids in their system, the drug rapidly strips those opioids off their receptors, triggering a sudden and intense withdrawal syndrome. This isn’t the gradual discomfort of natural withdrawal; it’s a compressed, severe version that can include vomiting, diarrhea, agitation, sweating, and a massive sympathetic nervous system surge.

That sympathetic surge can send blood pressure and heart rate skyrocketing. The clinical literature describes precipitated withdrawal from long-acting opioid antagonists as a medical emergency requiring monitoring and supportive care. The blood pressure changes in this context aren’t a pharmacological effect of naltrexone on the cardiovascular system per se. They’re a secondary consequence of the body going into crisis when its opioid equilibrium is violently disrupted. The cardiovascular stress of precipitated withdrawal can be severe enough to require emergency treatment.

This is why there’s a mandatory opioid-free waiting period before starting naltrexone, typically seven to ten days for short-acting opioids and even longer for methadone or other long-acting formulations. Practitioners who prescribe extended-release naltrexone often use a naloxone challenge test first: a small dose of the short-acting antagonist naloxone to see whether the patient goes into withdrawal before committing them to a long-acting formulation that can’t be removed once injected. If you’re transitioning from opioid use to naltrexone treatment, this waiting period isn’t optional, and the blood pressure risks of getting it wrong are one of the key reasons.

Naltrexone’s Protective Effects in Extreme Conditions

In a somewhat surprising twist, animal research has also identified scenarios where naltrexone may actually protect against dangerous drops in blood pressure. In a rat model of heat stroke, naltrexone given before heat exposure significantly attenuated the hypotension (dangerously low blood pressure) that normally accompanies severe overheating. The drug also reduced the spike in beta-endorphin, the body’s own opioid released in large quantities during heat stress, and improved survival.⁷ Timing mattered: when naltrexone was given 20 minutes before heat exposure it was protective, but giving it after heat stroke had already begun didn’t help.

This finding isn’t clinically actionable for humans at this point. Nobody is going to take naltrexone before a hot day as a cardiovascular precaution. But it does reinforce the broader theme: endogenous opioids are active participants in cardiovascular regulation, especially during stress, and blocking them with naltrexone can meaningfully shift the balance. In cases where the body’s opioid response is itself part of the problem (contributing to vascular collapse during heat stroke, or amplifying a hypertensive spike during stress), blocking that response helps. In cases where the opioid system is contributing constructively to cardiovascular stability, blocking it could theoretically make things worse.

Low-Dose Naltrexone and Blood Pressure

A growing number of people take naltrexone at very low doses, typically between 1.5 and 4.5 mg, for off-label uses including chronic pain, autoimmune conditions, and fibromyalgia. These doses are a fraction of the standard 50 mg daily dose used in addiction medicine. The pharmacological logic behind low-dose naltrexone (LDN) is different from standard dosing: at very low doses, the brief, partial blockade of opioid receptors may trigger a rebound upregulation of endorphin production and opioid receptor sensitivity.

There’s essentially no published clinical trial data specifically examining low-dose naltrexone’s effects on blood pressure. The cold pressor study mentioned earlier used the full 50 mg dose and found no blood pressure effect in healthy people. It’s reasonable to expect that a dose one-tenth to one-thirtieth that size would have even less cardiovascular impact, but that’s an extrapolation rather than a proven finding. Anecdotal reports in LDN communities are mixed, with some people reporting lower blood pressure readings and others reporting no change. Until someone runs a controlled trial, the best honest answer is that LDN probably doesn’t affect blood pressure meaningfully, but the word “probably” is doing real work in that sentence.

Alcohol, Naltrexone, and Your Heart Rate

Many people take naltrexone specifically to reduce alcohol cravings and consumption. Alcohol itself has well-documented cardiovascular effects: it can raise heart rate, transiently increase blood pressure during and immediately after drinking, and over time contribute to hypertension and cardiomyopathy. One of naltrexone’s therapeutic effects in alcohol use disorder is dampening the rewarding response to alcohol. Research has suggested that naltrexone may also dampen alcohol-induced cardiovascular activation, blunting the heart rate and blood pressure increases that typically accompany drinking.

For someone taking naltrexone to manage drinking, this has a practical implication. If the drug both reduces how much you drink and softens the cardiovascular jolt of whatever drinking you do, it may indirectly improve your blood pressure trajectory over months. But this is an indirect benefit of reduced alcohol intake and blunted stress responses, not a direct antihypertensive effect of the drug. It’s the sort of thing that wouldn’t show up as “naltrexone lowers blood pressure” in a clinical trial but might show up as improved cardiovascular health over a year of treatment.

When to Monitor and When Not to Worry

If you’re starting naltrexone as a standalone medication for alcohol use disorder and your blood pressure is normal, routine blood pressure monitoring beyond what you’d do for any other medication start is probably unnecessary. The evidence consistently suggests the drug has negligible direct effects on blood pressure in normotensive individuals.⁴

There are a few situations where closer attention makes sense:

Naltrexone-bupropion: The combination product warrants blood pressure checks, especially early in treatment. The systolic effect is real and clinically relevant, particularly in people already near or above hypertensive thresholds.⁶
Opioid use disorder treatment: Blood pressure may shift during the transition to naltrexone, and the direction depends on the opioid you were using. Your treatment team should be tracking vitals during induction anyway.⁵
Existing hypertension: While some evidence suggests opioid antagonists might transiently lower blood pressure during acute elevations, this is not a reason to change your antihypertensive regimen. Mention naltrexone to whoever manages your blood pressure medications.
Risk of precipitated withdrawal: If there’s any uncertainty about whether opioids are still in your system, the cardiovascular risks of precipitated withdrawal make the timing of naltrexone initiation a safety-critical decision.

Home blood pressure monitors are inexpensive and widely available. If you’re starting any new medication and want peace of mind, taking readings for the first couple of weeks and comparing them to your baseline is a low-effort way to catch any unusual changes early, regardless of what the clinical literature predicts for your situation.